Replies to post #1367 on CardioVascular BioTherapeutics (fka CVBT)

[johnnyblades2001]

This article about the conference may interest you. Both cardiovascular disease and Parkinson's mentioned. Venturis has two drugs in its pipeline that address these huge unmet needs. A perfect place to be.

https://www.fiercebiotech.com/biotech/jpm-biotech-and-vc-execs-where-industry-should-look-beyond-cancer

[SMYDDI1975]

I met him on Monday before his meetings. He said he would reach out to me next week. As a matter of record, you can call him in the USA on 714.280.2527. Unlike what has been reported he always gets back to me within a day or two. You should make the most of it because after the IPO you will have to rely on what's in the public domain.